Why This Biotech Fund Increased Its Oruka Stake Amid a 500% Rally
A biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Discover various ways to save and invest in 2023 that will help you grow your finances and achieve your financial goals.
28,655 articlesA biotech fund just boosted its Oruka Therapeutics position after a blistering rally. Here’s what the move signals ab...
Two Vermont measures push factory-built housing toward broader affordability, clearing key committee hurdles and movi...
Ripple advances toward a national bank charter, triggering headlines and trading shifts for XRP. Experts weigh how wh...
As AI data centers expand, SanDisk Corporation is drawing new investor interest. The stock has moved higher on expect...
Alphabet stands out as a durable cash engine blending a near-monopoly ad business with AI-driven cloud gains, offerin...
Insider sales in biotech can spark questions about a company’s future. This guide breaks down what to watch, how to r...
A growing cohort of Bitcoin veterans is converting crypto gains into hardened security, from armored vehicles to unde...
A consortium-backed stablecoin called OpenUSD is gaining serious market attention as more than 140 firms back the pro...
In June, gold and silver prices pulled back, pressuring Hycroft Mining, a Nevada-focused, single-mine precious metals...
Beazer Homes faces a pivotal moment as Dream Finders increases its cash bid to $32 per share, intensifying the beazer...
When the market teeters, the smartest investors lean on history and discipline. Discover a single, proven move you ca...
Immunova has moved to acquire AlphaTON's cancer-treatment subsidiary, Iox Therapeutics, in a deal that signals a stra...